Mesi Mathew, Isaac Gundu, Afeez Ajibade Aruna, Samuel Isa Gana, Muhammad Raji Mahmud, Abdullahi Onimisi Jimoh
{"title":"额部幽灵瘤:病例报告","authors":"Mesi Mathew, Isaac Gundu, Afeez Ajibade Aruna, Samuel Isa Gana, Muhammad Raji Mahmud, Abdullahi Onimisi Jimoh","doi":"10.1186/s41984-024-00285-6","DOIUrl":null,"url":null,"abstract":"Ghost tumors spontaneously disappear or decrease to less than 70% before definitive diagnosis and treatment (other than steroid treatment). We report our experience with a patient who had not received steroids, and the challenges of managing a ghost tumor from a developing country. A 71 year old female with frontal mass, right proptosis, and frontal headache. Mass was confirmed by cranial CT scan but entirely resolved while the patient was awaiting surgery. Further follow-up at 6 months revealed clinical and MRI evidence of recurrence. Ghost tumors are no myths and can recur! It is imperative to closely follow up with patients who have complete resolution of brain tumors prior to definitive treatment.","PeriodicalId":72881,"journal":{"name":"Egyptian journal of neurosurgery","volume":"49 1","pages":""},"PeriodicalIF":0.7000,"publicationDate":"2024-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Frontal ghost tumour: a case report\",\"authors\":\"Mesi Mathew, Isaac Gundu, Afeez Ajibade Aruna, Samuel Isa Gana, Muhammad Raji Mahmud, Abdullahi Onimisi Jimoh\",\"doi\":\"10.1186/s41984-024-00285-6\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Ghost tumors spontaneously disappear or decrease to less than 70% before definitive diagnosis and treatment (other than steroid treatment). We report our experience with a patient who had not received steroids, and the challenges of managing a ghost tumor from a developing country. A 71 year old female with frontal mass, right proptosis, and frontal headache. Mass was confirmed by cranial CT scan but entirely resolved while the patient was awaiting surgery. Further follow-up at 6 months revealed clinical and MRI evidence of recurrence. Ghost tumors are no myths and can recur! It is imperative to closely follow up with patients who have complete resolution of brain tumors prior to definitive treatment.\",\"PeriodicalId\":72881,\"journal\":{\"name\":\"Egyptian journal of neurosurgery\",\"volume\":\"49 1\",\"pages\":\"\"},\"PeriodicalIF\":0.7000,\"publicationDate\":\"2024-04-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Egyptian journal of neurosurgery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1186/s41984-024-00285-6\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Egyptian journal of neurosurgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s41984-024-00285-6","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
Ghost tumors spontaneously disappear or decrease to less than 70% before definitive diagnosis and treatment (other than steroid treatment). We report our experience with a patient who had not received steroids, and the challenges of managing a ghost tumor from a developing country. A 71 year old female with frontal mass, right proptosis, and frontal headache. Mass was confirmed by cranial CT scan but entirely resolved while the patient was awaiting surgery. Further follow-up at 6 months revealed clinical and MRI evidence of recurrence. Ghost tumors are no myths and can recur! It is imperative to closely follow up with patients who have complete resolution of brain tumors prior to definitive treatment.